A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity

Inclusion Criteria

• •1. Female or male aged 18 to 75 years
• •2. Body mass index (BMI) of:
• •1. ≥ 30 kg/m\^2 to \< 50 kg/m\^2
• •OR
• •2. ≥ 27 kg/m\^2 to \< 30 kg/m\^2 with at least 1 weight-related comorbidity
• •3. HbA1c \< 6.5%
• •4. Stable self-reported body weight for at least 3 months prior to study (\< 5% body weight gain or loss)